According to a study by Sierralta et al., the addition of an active site of AFP consisting of cyclized 9-amino acid peptide (cP) to MCF-7 breast cancer cells and estrogen-dependent ZR75-1 cells inhibited cell proliferation (37). The gene discussed is AFP; the disease is breast carcinoma.